Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China
· Delayed Price · Currency is CNY 39.96
+0.07 (0.18%)
Apr 29, 2026, 3:00 PM CST
SHA:600329 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 2,131 | 2,229 | 986.71 | 861.79 | 769.14 | Upgrade
|
| Depreciation & Amortization | 111.32 | 125.94 | 130.13 | 116.56 | 115.53 | Upgrade
|
| Other Amortization | 13.72 | 2.27 | 3.03 | 4.11 | 2.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.83 | -0.11 | -0.15 | -1.08 | -12.32 | Upgrade
|
| Asset Writedown & Restructuring Costs | 117.71 | 113.8 | 44.36 | 20.16 | 1.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,646 | -1,908 | -308.11 | -274.22 | -213.49 | Upgrade
|
| Provision & Write-off of Bad Debts | 7.41 | 44.78 | 19.09 | 9.22 | 4.89 | Upgrade
|
| Other Operating Activities | 16.59 | 39.39 | 38.92 | 54.02 | 32.68 | Upgrade
|
| Change in Accounts Receivable | -260.42 | 26.25 | 74.01 | -732.29 | -42.07 | Upgrade
|
| Change in Inventory | 117.73 | 21.95 | -165.34 | 58.87 | -47.4 | Upgrade
|
| Change in Accounts Payable | -113.1 | 288.5 | -56.06 | 609.67 | 220.2 | Upgrade
|
| Change in Other Net Operating Assets | - | -0.02 | -18.98 | 6.82 | 10.15 | Upgrade
|
| Operating Cash Flow | 461.07 | 924.67 | 688.49 | 677.25 | 852.4 | Upgrade
|
| Operating Cash Flow Growth | -50.14% | 34.30% | 1.66% | -20.55% | 26.96% | Upgrade
|
| Capital Expenditures | -118.61 | -117.81 | -140.93 | -107.9 | -156.95 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.39 | 0.08 | 0.19 | 1.49 | 28.71 | Upgrade
|
| Cash Acquisitions | - | - | - | -47.61 | - | Upgrade
|
| Divestitures | - | -347.8 | - | - | - | Upgrade
|
| Investment in Securities | -1,310 | 805.42 | -606.35 | -65.08 | -334.92 | Upgrade
|
| Other Investing Activities | 20.66 | 2.42 | 178.18 | 206.82 | 151.3 | Upgrade
|
| Investing Cash Flow | -1,408 | 342.31 | -568.91 | -12.28 | -311.85 | Upgrade
|
| Long-Term Debt Issued | 5 | 1,221 | 870.86 | 205.65 | - | Upgrade
|
| Total Debt Issued | 5 | 1,221 | 870.86 | 205.65 | - | Upgrade
|
| Long-Term Debt Repaid | -4.6 | -522.3 | -807.34 | -39.87 | -1.42 | Upgrade
|
| Total Debt Repaid | -4.6 | -522.3 | -807.34 | -39.87 | -1.42 | Upgrade
|
| Net Debt Issued (Repaid) | 0.4 | 698.77 | 63.52 | 165.78 | -1.42 | Upgrade
|
| Repurchase of Common Stock | - | -0.28 | -22.67 | - | -1.35 | Upgrade
|
| Common Dividends Paid | -981.29 | -1,011 | -877.33 | -387.43 | -232.06 | Upgrade
|
| Other Financing Activities | - | -7.79 | 2.7 | -14.96 | -9.87 | Upgrade
|
| Financing Cash Flow | -980.88 | -319.89 | -833.77 | -236.62 | -244.7 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.22 | -0.04 | 0.05 | 0.01 | - | Upgrade
|
| Net Cash Flow | -1,928 | 947.05 | -714.15 | 428.35 | 295.85 | Upgrade
|
| Free Cash Flow | 342.45 | 806.86 | 547.56 | 569.34 | 695.45 | Upgrade
|
| Free Cash Flow Growth | -57.56% | 47.36% | -3.83% | -18.13% | 44.21% | Upgrade
|
| Free Cash Flow Margin | 6.96% | 11.04% | 6.66% | 6.90% | 10.07% | Upgrade
|
| Free Cash Flow Per Share | 0.45 | 1.05 | 0.71 | 0.73 | 0.90 | Upgrade
|
| Cash Income Tax Paid | 1,210 | 751.63 | 765.94 | 526.93 | 496.73 | Upgrade
|
| Levered Free Cash Flow | 2,066 | 1,818 | 360.35 | 961.19 | 149.46 | Upgrade
|
| Unlevered Free Cash Flow | 2,072 | 1,843 | 382.76 | 967.61 | 151.29 | Upgrade
|
| Change in Working Capital | -288.14 | 277.05 | -225.49 | -113.32 | 151.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.